Trial Profile
An Open Label, Multicenter Study Evaluating Safety and Tolerability of Creon Micro in Pediatric Subjects From at Least One Month to Less Than Four Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2015
Price :
$35
*
At a glance
- Drugs Pancreatin (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 22 Jan 2015 New trial record
- 09 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.